Protein Binding Determination of Cefepime, Flucloxacillin, Meropenem, Piperacillin and Tazobactam by Ultrafiltration in Critically Ill Patients: The Choice of Device Matters. [PDF]
Gregoire M +6 more
europepmc +1 more source
Trends in the Frequency and Antimicrobial Resistance of Common Gram-Negative Bacilli Isolated From Urine Cultures. [PDF]
Castellano-Sánchez L +5 more
europepmc +1 more source
<i>Serratia marcescens</i> peritonitis in a continuous ambulatory peritoneal dialysis patient: A case report and literature review. [PDF]
Altınyüzük O +5 more
europepmc +1 more source
A Disproportionality Analysis of β-lactam Antibiotic Related Blood and Lymphatic System Disorders Based on the FDA Adverse Event Reporting System Database. [PDF]
Liu J +6 more
europepmc +1 more source
Real-life evaluation of BioFire® BCID2 and Vitek® REVEALTM for Gram-negative bloodstream infections in critical care. [PDF]
Benyahia M +9 more
europepmc +1 more source
Post-Marketing Reporting Patterns of Ceftazidime-Avibactam and Ceftolozane-Tazobactam: Analysis of Adverse Event Reports from EudraVigilance. [PDF]
Gianguzzo VM +8 more
europepmc +1 more source
A pharmacist-led, workplace-based educational intervention informed by behavioral science to influence antimicrobial prescribing in Japan. [PDF]
Masuda K +7 more
europepmc +1 more source
Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms-a narrative review for an enablement strategy. [PDF]
Eckmann C +16 more
europepmc +1 more source
<i>In vivo</i> emergence of ceftazidime/avibactam resistance in <i>Pseudomonas aeruginosa</i> driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2. [PDF]
Pérez-Rodríguez G +8 more
europepmc +1 more source
Patterns and potential indications of WHO AWaRe Watch antibiotic use across UK community and hospital care: a national observational study. [PDF]
Rowlands EJ +30 more
europepmc +1 more source

